Pharmacotherapy of postpartum depression: Current practice and future directions

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 12, 2005, Pages 1999-2005

  Tcheremissine, Oleg V ^a   Lieving, Lori M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Clinical trials; Pharmacotherapy; Postpartum depression

Indexed keywords

CITALOPRAM; ESTRADIOL; FLUOXETINE; PAROXETINE; PLACEBO; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEX HORMONE;

BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; DEEP VEIN THROMBOSIS; DEPRESSION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ENDOMETRIUM HYPERPLASIA; FEMALE; FLUID RETENTION; HIGH RISK POPULATION; HUMAN; POPULATION DISTRIBUTION; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DRUG EXPOSURE; PUERPERAL DEPRESSION; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; PROSPECTIVE STUDIES;

EID: 27744436452     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.12.1999     Document Type: Review

References (58)

1. ISHAK WW, RAPAPORT MH, GOTTO JG: Emerging treatment options in treatment-resistant depression and anxiety disorders. CNS Spectr. (2004) 9(14):25-32.
2. WEISSMAN M, OLFSON M: Depression in women: implications for health care research. Science (1995) 269:799-801.
3. O'HARA M, SWAIN A: Rates and risk of post-partum depression - a meta-analysis. Int. Rev. Psychiatry (1996) 8:37-54.
4. MURRAY L, COOPER P: Postpartum depression and child development. Psychol. Med. (1997) 27:253-260.
5. AMERICAN PSYCHIATRIC ASSOCIATION: In: Text Revision. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association, Washington, DC (2000).
6. CHAUDRON L: Postpartum depression: what pediatricians need to know. Pediatr. Rev. (2003) 24:154-160.
7. DENNIS CL: Can we identify mothers at-risk for postpartum depression in the immediate postpartum period using the Edinburgh Postnatal Depression Scale? J. Affect. Disord. (2004) 78:163-169.
8. WORLD HEALTH ORGANIZATION: Tenth revision of the International Classification of Disease, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagoostical Guidelines. Geneva, World Health Organization (1991).
9. COX JL, DECLAN M, CHAMAN G: A controlled study of the onset, duration and prevalence of postnatal depression. Br. J. Psychiatry (1993) 163:27-31.
10. COPPEN A: The biochemistry of affective disorders. Br. J. Psychiatry (1967) 113:1237-1264.
11. LAPIN IP, OXENKRUG GF: Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet (1969) 1:132-136.
12. SLATTERY DA, HUDSON AL, NUTT DJ: Invited review: the evolution of antidepressant mechanisms. Fundam. Clin. Pharmacol. (2004) 18:1-21.
13. LOGSDON MC, WISNER KL, HANUSA BH, PHILLIPS A: Role functioning and symptom remission in women with postpartum depression after antidepressant treatment. Arch. Psychiatr. Nurs. (2003) 17:276-283.
14. STOWE ZN, CASARELLA J, LANDRY J, NEMEROFF CB: Sertraline in the treatment of women with postpartum major depression. Depression (1995) 3:49-55.
15. SURI R, BURT VK, ALTSHULER LL, ZUCKERBROW-MILLER J, FAIRBANKS L: Fluvoxamine for postpartum depression. Am. J. Psychiatry (2001) 158:1739-1740.
16. KENDELL RE, CHALMERES JC, PLATZ C: Epidemiology of puerperal psychoses. Br. J. Psychiatry (1987) 150:662-673.
17. YONKERS KA, RAMIN SM, RUSH AJ et al.: Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am. J. Psychiatry (2001) 158:1856-1863.
18. MACQUEEN G, CHOKKA P: Special issues in the management of depression in women. Can. J. Psychiatry (2004) 49 (1):27-40.
19. WISNER KL, PEREL JM, PEINDL KS, HANUSA BH, FINDLING RL, RAPPORT DJ: Prevention of recurrent postpartum depression: a randomized clinical trial. J. Clin. Psychiatry (2001) 62:82-86.
20. WISNER KL, PEREL JM, PEINDL KS, HANUSA BH, PIONTEK CM, FINDLING RL: Prevention of postpartum depression: a pilot randomized clinical trial. Am. J. Psychiatry (2004) 161:1290-1292.
21. WISNER KL, PARRY BL, PIONTEK CM: Clinical practice; postpartum depression. N. Engl. J. Med. (2002) 347:194-199.
22. ANDERSON IM, NUTT DJ, DEAKIN JWF: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J. Psychopharmacol. (2000) 14:3-20.
23. APPLEBY L, WARNER R, WHITTON A, FARAGHER B: A controlled study of fluoxetine and cognitive-behavioral counseling in the in the treatment of postnatal depression. Br. Med. J. (1997) 314:932-936.
24. MISRI S, REEBYE P, CORRAL M et al.: The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J. Clin. Psychiatry (2004) 65:1236-1241.
25. SANZ EJ, DE-LAS-CUEVAS C, KIURU A, BATE A, EDWARDS R: Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet (2005) 365:482-487.
26. NULMAN I, ROVET J, STEWART DE et al.: Neurodevelopment of children exposed in utero to antidepressant drugs. N. Engl. J. Med. (1997) 4:258-262.
27. HEIKKINEN T, EKBLAD U, KERO P et al.: Citalopram in pregnancy and lactation. Clin. Pharmacol. Ther. (2002) 2:184-191.
28. SIMON GE, CUNNINGHAM ML, DAVIS RL: Outcomes of prenatal antidepressant exposure. Am. J. Psychiatry (2002) 12:2055-2061.
29. CASPER RC, FLEISHER BE, LEE-ANCAJAS JC et al.: Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J. Pediatr. (2003) 4:402-408.
30. IQBAL MM, SOBHAN T, RYALS T: Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Pychiatr. Serv. (2002) 53:39-49.
31. LLEWELLYN A, STOWE ZN: Psychotropic medications in lactation. J. Clin. Psychiatry (1998) 59(Suppl. 2):41-52.
32. LUNDMARK J, REIS M, BENGTSSON F: Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical trials. Ther. Drug. Monit. (2000) 22:446-454.
33. YOSHIDA K, SMITH B, CRAGGS M et al.: Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br. J. Psychiatry (1998) 172:175-178.
34. BRENT NB, WISNER KL: Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin. Pediatr. (1998) 1:41-44.
35. STOWE ZN, COHEN LS, HOSTETTER A et al.: Paroxetine in human breast milk and nursing infants. Am. J. Psychiatry (2000) 2:18 5-189.
36. WISNER KL, PEREL JM, BLUMER J: Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am. J. Psychiatry (1998) 5:690-692.
37. NEWPORT DJ, STOWE ZN: Clinical management of perinatal depression; focus on paroxetine. Psychopharmacol. Bull. (2003) 37:148-166.
38. NOTT PN, FRANKLIN M, ARMITAGE C, GELDER MG: Hormonal changes and mood in the puerperium. Br. J. Psychiatry (1976) 128:379-383.
39. HARRIS B, LOVETT L, SMITH J, READ G, WALKER R, NEWCOMBE R: Cardiff puerperal mood and hormone Study III. Postnatal depression at 5 to 6 weeks postpartum and its hormone correlates across the peripartum period. Br. J. Psychiatry (1996) 168:739-744.
40. DALTON K: Progesterone prophylaxis used successfully in postnatal depression. Practitioner (1985) 229:507-508.
41. DALTON K: Successful prophylactic progesterone for idiopathic postnatal depression. Int. J. Perinatal Studies (1989) 1:322-327.
42. LAWRIE TA, HOFMEYR GJ, DEJAGER M, BERK M, PAIKR J, VILJOEN E: A double-blind randomized placebo controlled trial of postnatal noresthisterone enanthate: the effect of postnatal depression and serum hormones. Br. J. Obstet. Gynecol. (1998) 105:1082-1090.
43. GREGOIRE AJP, KUMAR R, EVERITT B, HENDERSON A, STUDD JWW: Transdermal oestrogen for treatment of severe postnatal depression. Lancet (1996) 347:930-933.
44. CHARNEY DS, BARLOW DH, BOTTERON KN et al.: Neuroscience research agenda to guide development of a pathophysiologically based classification system. In: A research agenda for DSM-V. Kupfer DJ, First MB, Regier DA (Eds). American Psychiatric Association, Washington, DC (2002):31-83.
45. COOPER PJ, CAMPBELL EA, DAY A, KENNERLEY H, BOND A: Non-psychotic psychiatric disorder after childbirth - a prospective study of prevalence, incidence, course and nature. Br. J. Psychiatry (1988) 152:799-806.
46. WHIFFEN VE: Is postpartum depression a distinct diagnosis? Clin. Psychol. Rev. (1992) 12:485-508.
47. PAFFENBARGER RS, MCCABE LJ: T he effect of obstetric and perinatal events on risk of mental illness in women of childbearing age. Am. J. Public Health Nations Health. (1966) 56:400-407.
48. WISNER KL, PEINDL K, HAPUSA BH: Relationship of psychiatric illness to childbearing status: a hospital-based epidemiologic study. J. Affect. Disord. (1993) 28:39-50.
49. FRANK E, KUPFER DJ, JACOB M, BLUMENTHAL SJ, JARRETT DB: Pregnancy-related affective episodes among women with recurrent depression. Am. J. Psychiatry (1987) 144:288-293.
50. HENDRIC V, ALTSHULER L, STROUSE T et al.: Postpartum and nnonpostpartun depression: differences in presentation and response to pharmacologic treatment. Depress. Anxiety (2000) 11:66-72.
51. FAVA M, UEBELACKER LA, ALPERT JE, NIERENBERG AA, PAVA JA, ROSENBAUM JF: Major depressive subtypes and treatment response. Biol. Psychiatry (1997) 42:568-576.
52. CLAYTON PJ: The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J. Clin. Psychiatry (1990) 51:35-39.
53. KHAN A, WARNER HA, BROWN WA: Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch. Gen. Psychiatry (2000) 57:311-317.
54. STOROSUM JG, VAN ZWIETEN BJ, VAN DEN BRINK W, GERSONS BPR, BROEKMANS AW: Suicide risk in placebo-controlled studies of major depression. Am. J. Psychiatry (2001) 158:1271-1275.
55. ROTHMAN KJ, MICHELS KB: The continuing unethical use of placebo controls. N. Engl. J. Med. (1994) 331:394-398.
56. WALSH BT, SEIDMAN SN, SYSKO R, GOULD M: Placebo response in studies of major depression: variable, substantial and growing. JAMA (2002) 287:1840-1847.
57. FAVA M, EVINS AE, DORER DJ, SCHOENFELD DA: The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother. Psychosom. (2003) 72:115-127.
58. HOROWITZ JA, GOODMAN JH: Identifying and treating postpartum depression. J. Obstet. Gynecol. Neonatal Nurs. (2004) 34:264-273.